πŸ‡ΊπŸ‡Έ FDA
Patent

US 7259278

Anti-S-phase tubulin ligands

granted A61KA61K45/06

Quick answer

US patent 7259278 (Anti-S-phase tubulin ligands) held by Cytoskeleton, Inc. expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cytoskeleton, Inc.
Grant date
Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K45/06